Altered function of insulin receptor substrate 1-deficient mouse islets and cultured β-cell lines

Journal of Clinical Investigation

Volumn 104, Issue 12, 1999, Pages

  Kulkarni, Rohit N ^a   Winnay, Jonathon N ^a   Daniels, Molly ^b   Brüning, Jens C ^a,d   Flier, Sarah N ^a   Hanahan, Douglas ^b   Kahn, C Ronald ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Hormone Research Institute   (United States)

^c JOSLIN DIABETES CENTER   (United States)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL LINE; CELL STRUCTURE; CONTROLLED STUDY; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SYNTHESIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0033379267     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8339     Document Type: Article

References (48)

1. Cheatham, B., and Kahn, C.R. 1995. Insulin action and the insulin signaling network. Endocr. Rev. 16:117-142.
2. White, M.F., and Yenush, L. 1998. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Curr. Top. Microbiol. Immunol. 228:179-208.
3. Caro, J.F., et al. 1987. Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin-dependent diabetes. J. Clin. Invest. 79:1330-1337.
4. Kerouz, N.J., Horsch, P., Pons, S., and Kahn, C.R. 1997. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J. Clin. Invest. 100:3164-3172.
5. Olefsky, J.M., and Nolan, J.J. 1995. Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms. Am. J. Clin. Nutr. 61:980S-986S.
6. Araki, E., et al. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature. 372:186-190.
7. Terauchi, Y., et al. 1997. Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic disease. J. Clin. Invest. 99:861-866.
8. Tamemoto, H., et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 372:182-186.
9. Withers, D.J., et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:900-904.
10. Bruning, J.C., et al. 1997. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell. 88:561-572.
11. Kulkarni, R.N., et al. 1999. Tissue-specific knock-out of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell. 96:329-339.
12. Leibiger, I.B., Leibiger, B., Moede, T., and Berggren, P.O. 1998. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase. Mol. Cell. 1:933-938.
13. Xu, G.G., and Rothenberg, P.L. 1998. Insulin receptor signaling in the β-cell influences insulin gene expression and insulin content. Diabetes. 47:1243-1252.
14. Aspinwall, C.A., Lakey, J.R., and Kennedy, R.T. 1999. Insulin-stimulated insulin secretion in single pancreatic beta cells. J. Biol. Chem. 274:6360-6365.
15. Kulkarni, R.N., et al. 1997. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J. Clin. Invest. 100:2729-2736.
16. Efrat, S., et al. 1988. Beta-cell lines derived from transgenic mice expressinga hybrid insulin geneoncogene. Proc. Natl. Acad. Sci. USA. 85:9037-9041.
17. Bonner-Weir, S., Deery, D., Leahy, J.L., and Weir, G.C. 1989. Compensatory growth of pancreatic β-cells in adult rats after short-rerm glucose infusion. Diabetes. 38:49-53.
18. Efrat, S., et al. 1993. Murine insulinoma cell line with normal glucose-regulated insulin secretion. Diabetes. 42:901-907.
19. Knaack, D.F.D.M., et al. 1994. Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes. 43:1413-1417.
20. D'Ambra, R., Surana, M., Efrat, S., Starr, R.G., and Fleischer, N. 1990. Regulation of insulin secretion from beta-cell lines derived from transgenic mice insulinomas resembles that of normal beta-cells. Endocrinology. 126:2815-2822.
21. Warram, J.H., Martin, B.C., Krolewski, A.S., Soeldner, J.S., and Kahn, C.R. 1990. Slow glucose removal rate and hyperinsulinemia are predictors of the risk of Type II diabetes in offspring of diabetic parents. Ann. Intern. Med. 113:909-915.
22. Martin, B.C., et al., 1992. Role of glucose and insulin resistance in development of Type II diabetes mellitus: results of a 25-year follow-up study. Lancet. 340:925-929.
23. Harbeck, M.C., Louie, D.C., Howland, J., Wolf, B.A., and Rothenberg, P.L. 1996. Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet β-cells. Diabetes. 45:711-717.
24. Rothenberg, P.L., Willison, L.D., Simon, J., and Wolf, B.A. 1995. Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting β-cells. Diabetes. 44:802-809.
25. Hugl, S.R., White, M.F., and Rhodes, C.J. 1998. IGF-1 stimulated pancreatic β-cell growth is glucose dependent: synergistic activation of IRS-mediated signal transduction pathways by glucose and IGF-1 in INS-1 cells. J. Biol. Chem. 273:17771-17779.
26. Velloso, L.A., Carneiro, E.M., Crepaldi, S.C., Boschero, A.C., and Saad, M.J. 1995. Glucose- and insulin-induced phosphorylation of the insulin receptor and its primary substrates IRS-1 and IRS-2 in rat pancreatic islets. Growth Regul. 377:353-357.
27. Taylor, S.I. 1999. Deconstructing type 2 diabetes. Cell. 97:9-12.
28. Bonner-Weir, S., Withers, D.J., Weir, G.C., and Jonas, J.C. 1999. Impaired survival of differentiating beta cells but no insulin secretory defects result form ablarion of IRS-2. Diabetes. 48:A3. (Abstr.)
29. Myers, M.G., Jr., et al. 1993. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinology. 132:1421-1430.
30. Postel-Vinay, M.C., and Kelly, P.A. 1996. Growth hormone receptor signalling. Baillieres Clin. Endocrinol. Metab. 10:323-336.
31. Bole-Feysot, C., Goffin, V., Edery, M., Binart, N., and Kelly, P.A. 1998. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knock-out mice. Endocr. Rev. 19:225-268.
32. Moldrup, A., Billestrup, N., Thorn, N.A., Lernmark, A., and Nielsen, J.H. 1989. Multiple growth hormone-binding proteins are expressed on insulin-producing cells. Mol. Endocrinol. 3:1173-1182.
33. Sorenson, R.L., and Stout, L.E. 1995. Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis. Endocrinology. 136:4092-4098.
34. Van Schravendijk, C.F., Foriers, A., Van den Brande, J.L. and Pipeleers, D.G. 1987. Evidence tor the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology. 121:1784-1788.
35. Sun, X.J., et al. 1997. The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. Mol. Endocrinol. 11:251-262.
36. Withers, D.J., et al. 1999. IRS-2 coordinates IGF-1 receptor-mediated beta cell development and peripheral insulin signalling. Nat. Genet. 23:32-40.
37. Krempler, F., Hell, E., Winkler, C., Breban, D., and Patsch, W. 1998. Plasma leptin levels: interaction of obesity with a common variant of insulin receptor substrate-1. Arterioscler. Thromb. Vasc. Biol 18:1686-1690.
38. + channels in pancreatic beta-cells. Diabetes. 46:1087-1093.
39. Porzio, O., et al. 1999. The Gly972 to Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic β cells, J. Clin. Invest. 104:357-364.
40. Laakso, M., Malkki, M., Kekalainen, P., Kuusisto, J., and Deeb, S.S. 1994. Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J. Clin. Invest. 94:1141-1146.
41. Almind, K., et al. 1993. Ammo acid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet. 342:828-832.
42. Imai, Y., et al. 1994. Variant sequences of insulin receptor substrate-1 in patients with noninsulin dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 79:1655-1658.
43. Zhang, Y., et al. 1996. UKPDS 19: Heterogeneity in NIDDM: separate contributions of IRS-1 and β3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study. Diabetologia. 39:1505-1511.
44. Cheatham, B., et al. 1994. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:4902-4911.
45. Schu, P.V., et al. 1993. Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science. 260:88-91.
46. Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., and Ui, M. 1994. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes: Studies with a selective inhibitor wortmannin. J. Biol. Chem. 269:3568-3573.
47. Yano, H., et al. 1993. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:25846-25856.
48. Shepherd, P.R., Withers, D.J., and Siddle, K. 1998. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem. J. 333:471-490.